Accelerator
MTPConnect kicks off $28.5 million health tech accelerator targeting heart disease and diabetes
Life sciences accelerator MTPConnect has teamed up with health tech industry giants CSL and Roche Diagnostics to launch a new program backing startups tackling cardiovascular disease (CVD) and diabetes. The $28.5 million Targeted Translation Research Accelerator (TTRA) is backed by the federal government’s $22 billion Medical Research Future Fund and will look to back promising drugs… Read more »
